SASS6 promotes tumor proliferation and is associated with TP53 and immune infiltration in lung adenocarcinoma
Clinical and Experimental Medicine · 24.10.2024 · 24 (1)
DOI: 10.1007/s10238-024-01510-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Medicine, online erschienen am 24.10.2024. Verfasst von Zihao Li und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Liuzhou People's Hospital affiliated to Guangxi Medical University, Liuzhou, Guangxi, China. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Cell Proliferation, Lung Neoplasms, Tumor Suppressor Protein p53. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The most common type of non-small cell lung cancer is lung adenocarcinoma (LUAD), which is characterized by high morbidity and poor survival. Up-regulation of SASS6 expression can lead to the progression of various malignant tumors. However, there are no relevant studies on the role of SASS6 in LUAD. SASS6 was highly expressed in most tumors, reflecting a good diagnostic value, and its overexpression in LUAD indicated discouraging overall prognosis. Functional enrichment analysis suggested that SASS6 was associated with cell cycle in LUAD. In addition, patients with high SASS6 expression had worse immune infiltration, but higher TMB and immune checkpoint, and higher sensitivity to multiple targeted drugs such as osimertinib. Cell experiments confirmed that knockdown of SASS6 could inhibit the viability of tumor cells.SASS6 has important value in the diagnosis of cancer. In particular, SASS6 is a crucial factor in the progression of LUAD, and has important clinical value, especially in the diagnosis, prognosis and treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thoracic Surgery, Liuzhou People's Hospital affiliated to Guangxi Medical University, Liuzhou, Guangxi, China.
- Department of Nephrology, Liuzhou People's Hospital affiliated to Guangxi Medical University, Liuzhou, Guangxi, China.
- Department of Cardio-Thoracic Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
- Department of Respiratory Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
- Department of Pediatric Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
- Department of Medical Oncology, Liuzhou People's Hospital affiliated to Guangxi Medical University, Liuzhou, Guangxi, China. huangjulu@stu.gxmu.edu.cn.
Zitieren
APA
Li, Z., He, L., Li, J., Qian, J., Wu, Z., Zhu, Y., Zhuo, T., Nong, J., Liang, H., Zheng, H., Huang, W., Huang, J., & Cao, J. (2024). SASS6 promotes tumor proliferation and is associated with TP53 and immune infiltration in lung adenocarcinoma. Clinical and Experimental Medicine, 24(1). https://doi.org/10.1007/s10238-024-01510-0
Vancouver
Li Z, He L, Li J, Qian J, Wu Z, Zhu Y, et al. SASS6 promotes tumor proliferation and is associated with TP53 and immune infiltration in lung adenocarcinoma. Clinical and Experimental Medicine. 2024;24(1). doi:10.1007/s10238-024-01510-0
BibTeX
@article{Li2024,
author = {Li, Zihao and He, Lingyun and Li, Jiayi and Qian, Jing and Wu, Zuotao and Zhu, Yongjie and Zhuo, Ting and Nong, Jusen and Liang, Honghua and Zheng, Hua and Huang, Weijia and Huang, Julu and Cao, Jianbin},
title = {SASS6 promotes tumor proliferation and is associated with TP53 and immune infiltration in lung adenocarcinoma},
journal = {Clinical and Experimental Medicine},
year = {2024},
volume = {24},
number = {1},
doi = {10.1007/s10238-024-01510-0}
}
EUVIMED